Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives

Publisher： Karger

E-ISSN： 1664-5553|6|2|101-112

ISSN： 2235-1795

Source： Liver Cancer, Vol.6, Iss.2, 2016-12, pp. : 101-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives

By Shen Ying-Chun   Hsu Chiun   Cheng Ann-Lii  

Journal of Gastroenterology, Vol. 45, Iss. 8, 2010-08 ,pp. : 794-807

Springer Publishing Company

Access to resources Recommend Favorite

Local ablation therapy for hepatocellular carcinoma: current status and future perspectives

By Kudo Masatoshi  

Journal of Gastroenterology, Vol. 39, Iss. 3, 2004-03 ,pp. : 205-214

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Targeted Therapy in Hepatocellular Carcinoma: Present Achievements and Future Challenges

By  

Digestive Diseases, Vol. 30, Iss. 3, 2012-06 ,pp. : 284-288

Karger

Access to resources Recommend Favorite

Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma

By  

Digestion, Vol. 96, Iss. 1, 2017-06 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

Why Does Every Hepatocellular Carcinoma Clinical Trial Using Molecular Targeted Agents Fail?

By  

Liver Cancer, Vol. 1, Iss. 2, 2012-09 ,pp. : 59-60

Karger

Access to resources Recommend Favorite